Filter
363
Filtered Results: 363
Text search:
National
Pharmacovigilance
Policy
Featured
Recommendations
44
New Publications
126
Language
Document type
No document type
204
Guidelines
58
Studies & Reports
46
Strategic & Response Plan
21
Manuals
18
Fact sheets
7
Training Material
5
Situation Updates
3
Infographics
1
Countries / Regions
Kenya
21
Nigeria
15
India
15
Ghana
14
Uganda
14
Western and Central Europe
13
Global
11
Eastern Europe
11
Nepal
10
Rwanda
10
South Africa
10
Namibia
9
Sierra Leone
7
Malawi
7
Ethiopia
7
Tanzania
6
Philippines
5
Congo, Democratic Republic of
5
South–East Asia Region
5
Liberia
5
Cambodia
4
West and Central Africa
4
Bangladesh
4
Russia
4
Zambia
4
Lesotho
3
Benin
3
Senegal
3
Zimbabwe
3
Mozambique
3
Latin America and the Carribbean
3
East and Southern Africa
3
Botswana
3
Ukraine
2
Syria
2
Africa
2
Haiti
2
Asia
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Sudan
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Cameroon
1
Laos
1
Burkina Faso
1
Afghanistan
1
Guinea
1
Jordan
1
Western Pacific Region
1
Maldives
1
Lebanon
1
Sri Lanka
1
Yemen
1
Georgia
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
187
Clinical Guidelines
44
Public Health
12
Women & Child Health
6
Capacity Building
5
Key Resources
5
Pharmacy & Technologies
4
Toolboxes
TB
45
Pharmacy
40
AMR
31
COVID-19
23
HIV
17
NTDs
15
NCDs
4
Ebola & Marburg
3
Specific Hazards
2
Refugee
2
Caregiver
2
Planetary Health
2
Rapid Response
1
Cholera
1
Malaria
1
Polio
1
Global Health Education
1
his Framework begins with a desired future scenario and considers actions and interventions necessary to get there. It advocates for holistic view to address tuberculosis. The Framework revisits challenges and actions in four layers: TB specific; challenges in health systems that influence TB care; ...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
Technical Update
HIV Treatment
July 2017
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
WHO Guidelines for malaria
recommended
25 Nov 2022
The WHO Guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform.
The WHO Guidelines for malaria supersedes 2 previous WHO publications: the Guidelines for the treatment of mala...
Recommendations for a public health approach
2010 revision
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of...
